XELIGEKIMAB
UNII MC5WXU879E

Substance Identification & Data

This profile provides standardized clinical and technical data for Xeligekimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MC5WXU879E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2382921-73-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
MC5WXU879E
CAS Registry Number
2382921-73-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
XELIGEKIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188599
National Cancer Institute reference terminology for clinical and research data.
INN ID
11625
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Xeligekimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

XELIGEKIMAB

Common Names & Synonyms

GR1501
GR-1501
IMMUNOGLOBULIN G4 (235-PROLINE), ANTI-(HUMAN INTERLEUKIN 17A) (HUMAN MONOCLONAL GR1501 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GR1501 .KAPPA.-CHAIN, DIMER
XELIGEKIMAB [INN]
XELIGEKIMAB [WHO-DD]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus